Advice for Life Science Start Ups
According to recent research* the percentage of small businesses that fail in the first year is 25%. This grows steadily in years two to three, before reaching 44% in year four for companies in the health industry, with only finance / insurance and real estate firms having a higher rate of failure. Pivotal Scientific focusses on start-ups and SMEs in the life science research sector of the health industry, providing companies with complete business advice and support in finding new customers and partners. Our success is purely down to the success of the companies that we work for.
It is for this reason that we decided to create a blog with articles contributed by individuals currently working in the industry; people who have experienced the ups and downs of working for small companies and eventually led them to long term growth and stability. The advice will cover all areas of setting up a business, including sales, marketing, building teams, networking and more. We hope you enjoy reading the articles and welcome your feedback!
* Source: Entrepreneur Weekly, Small Business Development Center, Bradley Univ, University of Tennessee Research – 1.1.2014
The Government’s industrial strategy green paper was launched in January, with the aim of addressing long-term challenges to the UK economy. It identified the life sciences industry as a dominant economic sector within the UK, generating approximately £64 billion of turnover, employing >200,000 scientists and staff, and providing an exceptional environment for businesses to emerge […]
As many western companies travel through Europe and the US to attend important events like AACC/ASCB|EMBO/MEDICA, it is usually quite productive to promote your brand through booth display or find business opportunities at these occasions. Accordingly, many important conferences/exhibitions are held in China every year and these could be great opportunities for international brands to […]
As we all know there is a great deal of in the Biological sector of the Chinese market however there could be some unexpected obstacles to gain profit in this unique market. The first frequent problem is in exporting to the Chinese market. According to the regulations in importing/exporting in China, the inspection and quarantine […]
Introduction This month we’ve picked a somewhat broad topic for the blog: The future. What are some of the things that should be on the mind of the forward-thinking supplier of research use only reagents? Of course, this is largely and necessarily speculation, but hopefully somewhat informed! There are two general, interlinked areas to think […]
Among all the ligand bioassays developed, the one which has emerged victorious is the Enzyme Linked Immuno Assay, or ELISA. Variations on the ELISA now have to power to discriminate antigens down to the femtomole/femtogramme (10-18 of a kilogramme) level, depending on how it’s implemented, offering researchers unprecedented levels of sensitivity. Harnessing the power of […]
The EU General Data Protection Regulation (GDPR) replaces the Data Protection Directive 95/46/EC in May 2018. Should we be concerned as businesses? I personally do not think that we need to be concerned but we should be prepared. So here are my thoughts on the pending change and how we may be able to prepare ourselves. Arguably the […]
Many international companies find that the Chinese research reagent market seems to be quite different than that in US or Europe. In the first years of entry to the market, it is quite difficult to analyze the potential, customer behavior and effective strategy for growth. Usually, it is easier to boost the sales with the help […]